Compare AU

Compare DRUG vs. IIGF

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare Currency Hedged ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare Currency Hedged ETF (DRUG) and the Intelligent Investor Aus Eq Grth Fund - Active ETF (IIGF). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

IIGF

Popularity

Low

Low

Pearlers invested

61

17

Median incremental investment

$920.50

$1,038.06

Median investment frequency

Monthly

Monthly

Median total investment

$1,892.10

$2,062.05

Average age group

26 - 35

> 35


Key Summary

DRUG

IIGF

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

IIGF.AX was created on 2020-10-05 by Intelligent Investor . The fund's investment portfolio concentrates primarily on total market equity. The portfolio aims to achieve a return of 2% above the S&P/ASX 200 Accumulation Index p.a. over five year rolling periods with minimal turnover to allow returns to compound in a favourable tax environment.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

RPMGlobal Holdings Ltd (10.13 %)

CSL Ltd (6.83 %)

New Hope Corp Ltd (5.72 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Other (28.42 %)

Consumer Discretionary (15.54 %)

Information Technology (15.39 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Australia (86.90 %)

New Zealand (7.31 %)

United States (5.79 %)

Management fee

0.57 %

0.97 %


Key Summary

DRUG

IIGF

Issuer

BetaShares

Intelligent Investor

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.97 %

Price

$7.95

$2.95

Size

$185.172 million

$101.651 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.90 %

5.21 %

Market

ASX

ASX

First listed date

08/08/2016

05/10/2020

Purchase fee

$6.50

$6.50


Community Stats

DRUG

IIGF

Popularity

Low

Low

Pearlers invested

61

17

Median incremental investment

$920.50

$1,038.06

Median investment frequency

Monthly

Monthly

Median total investment

$1,892.10

$2,062.05

Average age group

26 - 35

> 35


Pros and Cons

DRUG

IIGF

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher exposure to AU market

  • Higher distribution yield

Cons

  • Lower exposure to AU market

  • Lower distribution yield

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

DRUG

IIGF

Lower exposure to AU market

Higher exposure to AU market

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home